Paul Sagan - Aug 12, 2021 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role: Director
Signature: /s/ Brian Sandstrom, as Attorney-in-Fact
Stock symbol: MRNA
Transactions as of: Aug 12, 2021
Transactions value $: $0
Form type: 4
Date filed: 8/13/2021, 04:08 PM
Previous filing: Jul 26, 2021
Next filing: Oct 15, 2021

Transactions Table

Type	Sym	Class	Transaction	Shares	Change %	Shares After	Date	Ownership	Footnotes
transaction	MRNA	Common Stock	Gift	-50K	-11.89%	370K	Aug 12, 2021	By: The Paul Sagan Revocable Trust	F1
holding	MRNA	Common Stock				17.2K	Aug 12, 2021	By: Erwin Park LLC	F2
holding	MRNA	Common Stock				76.5K	Aug 12, 2021	By: The Chatham Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported disposition represents a bona fide charitable gift made by the reporting person.
F2	Erwin Park LLC is an estate planning vehicle for the Reporting Person's family. The Chatham Trust is an irrevocable family trust for which the Reporting Person serves as a trustee. The Paul Sagan Revocable Trust is a revocable trust for which the Reporting Person serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Content

The reported disposition represents a bona fide charitable gift made by the reporting person.

Erwin Park LLC is an estate planning vehicle for the Reporting Person's family. The Chatham Trust is an irrevocable family trust for which the Reporting Person serves as a trustee. The Paul Sagan Revocable Trust is a revocable trust for which the Reporting Person serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.